PDCA循环管理方法在我院重点监控药品管理中的应用及效果评价

Effectiveness of PDCA cycle on the key monitored drugs usage rationality in our hospital

目的促进医院重点监控药品的临床合理使用。方法全院多部门合作,采用PDCA循环管理方法,通过现状分析、制定管理措施并实施、检查管理结果并处理,对重点监控药品的临床使用进行干预,比较干预前和干预后药品使用情况。结果自2017年11月全面实行PDCA循环管理以来,重点监控药品每月使用总金额总体呈下降趋势。2017年11月至2018年10月重点监控药品使用总金额比PDCA实施前同期减少21.16%,其中辅助性用药和注射用质子泵抑制剂使用金额下降明显。注射用长春西汀、丙氨酰谷氨酰胺注射液和纳洛酮注射液等辅助性用药,以及注射用质子泵抑制剂的临床使用合理率得到了显著提高。结论采用PDCA循环管理模式对重点监控药品临床使用进行专项整治,取得了一定成效,将作为医院药事管理的重要组成部分得到持续开展。

AIM To promote the rational use of key monitored drugs in a classⅢgrade A comprehensive hospital.METHODS The PDCA cycle management method was adopted to intervene the clinical use of key monitored drugs with the cooperation of multiple departments in the hospital.The drug use before and after the intervention was compared through the analysis of the current situation,the implementation of management measures and the inspection of management results.RESULTS Since the implementation of PDCA cycle management in the hospital in November 2017,the total amount of monthly use of key monitored drugs had been decreasing.From November 2017 to October 2018,the total amount of key monitored drugs was 21.16%less than that before PDCA cycle managment,among which the amount of adjuvant drugs and proton pump inhibitors(PPIs)for injections was significantly reduced.The rational rate of clinical use of vinpocetine injection,alanyl glutamine injection,naloxone injection and other adjuvant drugs,as well as PPIs injections had been significantly improved.CONCLUSION PDCA cycle management mode is adopted to carry out special rectification for the clinical use of key monitored drugs in the hospital,which has achieved certain results and will continue to be carried out as an important part of pharmaceutical affairs management.